Long Shan Li

928 total citations
16 papers, 709 citations indexed

About

Long Shan Li is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Long Shan Li has authored 16 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in Long Shan Li's work include Genetic factors in colorectal cancer (7 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Cancer Genomics and Diagnostics (4 papers). Long Shan Li is often cited by papers focused on Genetic factors in colorectal cancer (7 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Cancer Genomics and Diagnostics (4 papers). Long Shan Li collaborates with scholars based in United States, South Korea and Singapore. Long Shan Li's co-authors include Hoguen Kim, David A. Boothman, Hyunki Kim, William G. Bornmann, Julio C. Morales, Mark W. Wagner, Hwanseok Rhee, Nam Kyu Kim, Erik A. Bey and Joon Chang and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.

In The Last Decade

Long Shan Li

16 papers receiving 694 citations

Peers

Long Shan Li

ONCOL

PFM

TOXIC

Jieru Meng United States

Stephanie Deangelis United States

Giacomo Cossa Italy

Jing-Yuan Liu United States

Christopher J. Matheson United States

Elizabeth Foust United States

David Paladino United States

Melinda Huang United States

Elisabetta Corna Italy

Nermin Kahraman United States

Jieru Meng United States

Long Shan Li

435 ×0.9

152 ×0.9

ONCOL

83 ×0.5

PFM

73 ×0.5

TOXIC

98 ×0.7

Citations per year, relative to Long Shan Li Long Shan Li (= 1×) peers Jieru Meng

Countries citing papers authored by Long Shan Li

Since Specialization

Citations

This map shows the geographic impact of Long Shan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long Shan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long Shan Li more than expected).

Fields of papers citing papers by Long Shan Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Long Shan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long Shan Li. The network helps show where Long Shan Li may publish in the future.

Co-authorship network of co-authors of Long Shan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Long Shan Li. A scholar is included among the top collaborators of Long Shan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Long Shan Li. Long Shan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Li, Long Shan, Kenneth E. Huffman, Huiyu Li, et al.. (2023). Abstract 2690: In vivo CRISPR screen identifies SOAT1 as a chemotherapy chemosensitizing target for non-small cell lung cancer (NSCLC). Cancer Research. 83(7_Supplement). 2690–2690. 1 indexed citations

Deb, Dhruba, Satwik Rajaram, Jill E. Larsen, et al.. (2017). Combination Therapy Targeting BCL6 and Phospho-STAT3 Defeats Intratumor Heterogeneity in a Subset of Non–Small Cell Lung Cancers. Cancer Research. 77(11). 3070–3081. 33 indexed citations

Cui, Xuelian, Yuan Zhang, Yang Yang, et al.. (2015). [Significance of NAD (P) H: quinone oxidoreductase 1 overexpression in prognostic evaluation of thyroid medullary carcinoma].. PubMed. 44(2). 128–9. 2 indexed citations

Cao, Lifen, Long Shan Li, Ling Xiao, et al.. (2014). Tumor-Selective, Futile Redox Cycle-Induced Bystander Effects Elicited by NQO1 Bioactivatable Radiosensitizing Drugs in Triple-Negative Breast Cancers. Antioxidants and Redox Signaling. 21(2). 237–250. 32 indexed citations

Bey, Erik A., Kathryn E. Reinicke, Melissa C. Srougi, et al.. (2013). Catalase Abrogates β-Lapachone–Induced PARP1 Hyperactivation–Directed Programmed Necrosis in NQO1-Positive Breast Cancers. Molecular Cancer Therapeutics. 12(10). 2110–2120. 84 indexed citations

Kim, Hyunki, Guihua Zhai, Sharon Samuel, et al.. (2013). Antagonistic Effects of Anti-EMMPRIN Antibody When Combined with Chemotherapy Against Hypovascular Pancreatic Cancers. Molecular Imaging and Biology. 16(1). 85–94. 9 indexed citations

Li, Long Shan, Erik A. Bey, Ying Dong, et al.. (2011). Modulating Endogenous NQO1 Levels Identifies Key Regulatory Mechanisms of Action of β-Lapachone for Pancreatic Cancer Therapy. Clinical Cancer Research. 17(2). 275–285. 94 indexed citations

Li, Long Shan, Julio C. Morales, Martina Veigl, et al.. (2009). DNA mismatch repair (MMR)‐dependent 5‐fluorouracil cytotoxicity and the potential for new therapeutic targets. British Journal of Pharmacology. 158(3). 679–692. 60 indexed citations

Wagner, Mark W., Long Shan Li, Julio C. Morales, et al.. (2008). Role of c-Abl Kinase in DNA Mismatch Repair-dependent G2 Cell Cycle Checkpoint Arrest Responses. Journal of Biological Chemistry. 283(31). 21382–21393. 26 indexed citations

10.

Li, Long Shan, Julio C. Morales, Arlene Hwang, Mark W. Wagner, & David A. Boothman. (2008). DNA Mismatch Repair-dependent Activation of c-Abl/p73α/GADD45α-mediated Apoptosis. Journal of Biological Chemistry. 283(31). 21394–21403. 28 indexed citations

11.

You, Kwon Tae, Long Shan Li, Hyun Ju Kang, et al.. (2007). Selective Translational Repression of Truncated Proteins from Frameshift Mutation-Derived mRNAs in Tumors. PLoS Biology. 5(5). e109–e109. 51 indexed citations

12.

Kim, Hyunki, Suk Woo Nam, Hwanseok Rhee, et al.. (2004). Different gene expression profiles between microsatellite instability-high and microsatellite stable colorectal carcinomas. Oncogene. 23(37). 6218–6225. 41 indexed citations

13.

Li, Long Shan, Hyunki Kim, Hwanseok Rhee, et al.. (2004). Proteomic analysis distinguishes basaloid carcinoma as a distinct subtype of nonsmall cell lung carcinoma. PROTEOMICS. 4(11). 3394–3400. 54 indexed citations

14.

Kim, Wun‐Jae, Joong-Kook Choi, Yong Hee Lee, et al.. (2003). Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochemical and Biophysical Research Communications. 314(1). 223–228. 105 indexed citations

15.

Li, Long Shan, Nam-Gyun Kim, Se Hoon Kim, et al.. (2003). Chromosomal Imbalances in the Colorectal Carcinomas with Microsatellite Instability. American Journal Of Pathology. 163(4). 1429–1436. 44 indexed citations

16.

Kim, Nam-Gyun, Hwanseok Rhee, Long Shan Li, et al.. (2002). Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genes in colorectal carcinomas with microsatellite instability. Oncogene. 21(33). 5081–5087. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact